CoChat

A three-country comparison of psychotropic medication prevalence in youth

Open access
Zito, Julie M, Safer, Daniel J, Berg, Lolkje TW de Jong-van den, Janhsen, Katrin, Fegert, Joerg M, Gardner, James F, Glaeske, Gerd, Valluri, Satish C · 2008 · Child and Adolescent Psychiatry and Mental Health

The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The study aims to compare cross-national prevalence of psychotropic medication use in youth. METHODS: A population-based analysis of psychotropic medication use based on administrative claims data for the year 2000 was undertaken for insured enrollees from 3 countries in relation to age group (0-4, 5-9, 10-14, and 15-19), gender, drug subclass pattern and concomitant use. The data include insured youth aged 0-19 in the year 2000 from the Netherlands (n = 110,944), Germany (n = 356,520) and the United States (n = 127,157). RESULTS: The annual prevalence of any psychotropic medication in youth was significantly greater in the US (6.7%) than in the Netherlands (2.9%) and in Germany (2.0%). Antidepressant and stimulant prevalence were 3 or more times greater in the US than in the Netherlands and Germany, while antipsychotic prevalence was 1.5-2.2 times greater. The atypical antipsychotic subclass represented only 5% of antipsychotic use in Germany, but 48% in the Netherlands and 66% in the US. The less commonly used drugs e.g. alpha agonists, lithium and antiparkinsonian agents generally followed the ranking of US>Dutch>German youth with very rare (less than 0.05%) use in Dutch and German youth. Though rarely used, anxiolytics were twice as common in Dutch as in US and German youth. Prescription hypnotics were half as common as anxiolytics in Dutch and US youth and were very uncommon in German youth. Concomitant drug use applied to 19.2% of US youth which was more than double the Dutch use and three times that of German youth. CONCLUSION: Prominent differences in psychotropic medication treatment patterns exist between youth in the US and Western Europe and within Western Europe. Differences in policies regarding direct to consumer drug advertising, government regulatory restrictions, reimbursement policies, diagnostic classification systems, and cultural beliefs regarding the role of medication for emotional and behavioral treatment are likely to account for these differences.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1753-2000-2-26

Cites

46 of 47 references verified1 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 47 references

Research works printed but not linked: 2

  1. Chiang CL: Standard error of the age-adjusted death rate. US Dept HEW: Vital Statistics Special Reports. 1961, 47: 271-285.
  2. Zito JM, Safer DJ, Fegert JM, Tobi H, Janhsen K, Glaeske G, Menis M, Ryu J: Neuroleptic prevalence for youths: a multi-national comparison. Poster presented at the annual meeting of the American Academy of Child and Adolescent Psychiatry Toronto. 2005

Cited by

See all 223

Metadata

Authors
Zito, J. M., Safer, D. J., Berg, L. T. D. J.-V. D., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C.
Affiliations
  • University of Maryland, Baltimore (US)
  • Johns Hopkins University (US)
  • University of Groningen (NL)
  • University of Bremen (DE)
Corresponding author
Zito, Julie M
Venue
Child and Adolescent Psychiatry and Mental Health
Published
2008-09-25
Volume
2
Issue
1
Pages
26-26
ISSN
1753-2000 (ISSN-L)
OpenAlex
W1996815465
Cited by
201
References
46
Citations by year
2026: 1 · 2025: 4 · 2024: 2 · 2023: 13 · 2022: 9 · 2021: 7 · 2020: 7 · 2019: 2 · 2018: 7 · 2017: 13 · 2016: 10 · 2015: 17 · 2014: 17 · 2013: 25 · 2012: 21
FWCI
20.51
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Child and Adolescent Psychiatry and Mental Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
psychotropic drugs, youth, cross-national comparison, antidepressants, stimulants, antipsychotic drugs, atypical antipsychotics, anxiolytics, concomitant drug use, drug use prevalence, health policy, Netherlands, Germany, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A three-country comparison of psychotropic medication prevalence in youth. https://app.cochat.ai/papers/10.1186/1753-2000-2-26
The paper
Zito, J. M., Safer, D. J., Berg, L. T. D. J.-V. D., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C. (2008). A three-country comparison of psychotropic medication prevalence in youth. Child and Adolescent Psychiatry and Mental Health. https://doi.org/10.1186/1753-2000-2-26

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.